| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |